In an attempt to clarify the role of K19 in breast cancer, we generated KRT19 knockout (KO) cell lines from MCF7 breast cancer cell line, which is estrogen receptor and progesterone receptor-positive (ER/PR+) and luminal in subtype22,23, and one of the breast cancer cell lines that highly express K194. This evidence concerns the gene ESR1 and breast carcinoma.